Said, S <br/><br/>
A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction.  [electronic resource] 

 -  Contraception  Sep 1986 
 - 223-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0010-7824 
<br/><br/><label>Standard No.: </label>10.1016/0010-7824(86)90004-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amenorrhea--chemically induced<br/>Blood Pressure<br/>Body Weight<br/>Clinical Trials as Topic<br/>Contraceptive Agents, Female<br/>Female<br/>Humans<br/>Medroxyprogesterone--administration & dosage<br/>Medroxyprogesterone Acetate<br/>Pregnancy<br/>Random Allocation